Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Where are we going?
| The first 150 words of the full text of this article appear below. |
From BMJ USA 2003;April:186
Whole body computed tomography (CT) screening is the focus of a major advertising campaign in the United States. Enticing testimonials on billboards and radio spots urge the public to use this technology, implying that there is much to gain and little to lose. How should primary care physicians advise their patients?
In one sense, CT screening does have much to offer. As part of a
National Institutes of Health study, our center has used CT to screen
for lung cancer for the past four years and has identified 56 lung
cancers. Fully 62% of the non-small cell cancers were stage
IA.1 In the absence of screening, only 15%-20% of lung
cancers present at stage IA. Five-year survival for stage I lung
cancers, which is approximately 60%-70%, is higher than that for
cancers diagnosed at more advanced stages. There is little doubt that
Department of Radiology, Mayo Clinic, Rochester, Minnesota. swensen.stephen@mayo.edu
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+